Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

224
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

389
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
389
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

258
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
258
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

379
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
379
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

316
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316
Heart Valves01:16

Heart Valves

10.8K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac remodelling and clinical outcomes after mitral edge-to-edge repair with the PASCAL® system.

European heart journal. Imaging methods and practice·2026
Same author

Right Ventricular Metrics as End Points in Clinical Trials: A Review.

JAMA cardiology·2026
Same author

Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Management of tricuspid regurgitation: time to adopt a lifetime perspective?

Annals of cardiothoracic surgery·2026
Same author

Transcatheter Tricuspid Valve Replacement: When do Signals Become Evidence?

The Canadian journal of cardiology·2026
Same author

Nine-Year Follow-Up After M-TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Related Experiment Video

Updated: Jan 10, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K

Choosing Between Tricuspid Repair or Replacement: Decision Algorithms.

Hannah Kempton1, Lukas Stolz1,2, Ludwug Weckbach1,2

  • 1Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany.

Structural Heart : the Journal of the Heart Team
|November 24, 2025
PubMed
Summary
This summary is machine-generated.

Transcatheter tricuspid valve (TV) interventions, including edge-to-edge repair and replacement (TTVR), offer options for severe tricuspid regurgitation (TR). Careful patient selection using a multidisciplinary approach is crucial for optimal outcomes.

Keywords:
Transcatheter tricuspid edge-to-edgeTranscatheter tricuspid valve interventionTricuspid regurgitation

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.1K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.1K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.1K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.1K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Transcatheter tricuspid valve (TV) interventions are evolving for treating TV disease.
  • Transcatheter tricuspid edge-to-edge repair shows promise for selected patients with severe tricuspid regurgitation (TR), improving symptoms and reducing hospitalizations.
  • Transcatheter TV replacement (TTVR) offers complete TR elimination but has limitations like availability and anticoagulation needs.

Purpose of the Study:

  • To present a framework for selecting the appropriate transcatheter TV intervention (repair vs. replacement) for patients with severe TR.
  • To emphasize the importance of individualized patient assessment and multidisciplinary care in procedural selection.
  • To propose a stepwise algorithm to guide decision-making in severe TR management.

Main Methods:

  • Review of current evidence and clinical experience in transcatheter TV interventions.
  • Highlighting key factors for procedural selection: TV anatomy, RV function, pulmonary pressures, device leads, bleeding risk, imaging, and anticoagulation tolerance.
  • Utilizing multimodal imaging (echocardiography, CT) and right heart catheterization for preprocedural planning and patient optimization.

Main Results:

  • Transcatheter tricuspid edge-to-edge repair and TTVR are complementary therapies tailored to patient-specific characteristics.
  • Optimal outcomes depend on comprehensive preprocedural evaluation and optimization, including diuresis, rhythm control, and specialist collaboration.
  • A proposed algorithm aids in selecting the best transcatheter approach for severe TR.

Conclusions:

  • Procedural selection for transcatheter TV interventions requires a thorough, multidisciplinary assessment.
  • Individualized evaluation of patient anatomy and clinical factors is paramount.
  • Both transcatheter tricuspid edge-to-edge repair and TTVR have distinct roles in managing severe TR.